Special Issue "Advances in Vaccine Development"
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (30 April 2021) | Viewed by 147277
Interests: RNA viruses; respiratory viruses; epithelial cells; siRNA; CRISPR-Cas; host genes; innate immunity; adaptive immunity; anti-viral immunity
Special Issues, Collections and Topics in MDPI journals
Special Issue in Vaccines: Feature Papers Collection on Influenza Vaccines
Special Issue in Vaccines: Pathobiology of Respiratory Syncytial Virus (RSV)
Topical Collection in Vaccines: COVID-19 Vaccines and Vaccination
We are glad to announce the Special Issue entitled “Advances in Vaccine Development”. We are soliciting reviews of manuscripts examining advances in gene delivery and expression, (nano)particles, proteins, and adjuvants creating the potential for new vaccine platforms. The review could cover strategic approaches for selecting vaccine antigens, formulations, or regimens, or review a field of vaccine research for specific diseases such as viruses. We would welcome a review or “perspective” discussing challenges ahead.
Prof. Dr. Ralph A. Tripp
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Cell-mediated Infectious disease